LION Trademark

Trademark Overview

On Thursday, September 1, 2022, a trademark application was filed for LION with the United States Patent and Trademark Office. The USPTO has given the LION trademark a serial number of 97979216. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 11, 2025. This trademark is owned by HDT Bio Corp.. The LION trademark is filed in the Pharmaceutical Products category with the following description:

Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of biologically active compositions in the form of cationic nanoparticles that facilitate the delivery of RNA to biological cells; Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of cationic nanoparticle emulsions that facilitate the delivery of RNA to biological cells; Drug delivery agents consisting of emulsions that facilitate delivery of RNA-based vaccines, namely delivery of RNA to biological cells for the prevention of infectious diseases
lion

General Information

Serial Number97979216
Word MarkLION
Filing DateThursday, September 1, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 14, 2025

Trademark Statements

Goods and ServicesNanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of biologically active compositions in the form of cationic nanoparticles that facilitate the delivery of RNA to biological cells; Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents consisting of cationic nanoparticle emulsions that facilitate the delivery of RNA to biological cells; Drug delivery agents consisting of emulsions that facilitate delivery of RNA-based vaccines, namely delivery of RNA to biological cells for the prevention of infectious diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 9, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHDT Bio Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98501
Party NameHDT Bio Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98501

Trademark Events

Event DateEvent Description
Friday, September 9, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 13, 2023NON-FINAL ACTION E-MAILED
Thursday, October 12, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, October 12, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Saturday, January 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 5, 2022NEW APPLICATION ENTERED
Saturday, June 17, 2023ASSIGNED TO EXAMINER
Saturday, January 13, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 13, 2023NON-FINAL ACTION WRITTEN
Thursday, July 13, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 15, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024FINAL REFUSAL E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, April 26, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, April 26, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, August 28, 2024DIVISIONAL REQUEST RECEIVED
Wednesday, August 28, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, August 28, 2024TEAS AMENDMENT OF USE RECEIVED
Wednesday, August 28, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, August 28, 2024EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, August 28, 2024JURISDICTION RESTORED TO EXAMINING ATTORNEY
Wednesday, August 28, 2024EX PARTE APPEAL-INSTITUTED
Tuesday, November 12, 2024ASSIGNED TO LIE
Tuesday, November 12, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 28, 2024FINAL REFUSAL WRITTEN
Thursday, November 14, 2024DIVISIONAL PROCESSING COMPLETE
Friday, December 20, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, December 20, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 20, 2024EXAMINERS AMENDMENT E-MAILED
Friday, December 20, 2024EXAMINER'S AMENDMENT ENTERED
Tuesday, January 14, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 14, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 8, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, September 10, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

lion delivery cells consisting facilitate biological nanoparticle agents drug based vaccines